Research and Blog Posts

Ketamine Infusions have shown to be effective in treating the following mood and paid disorders and conditions with growing evidence for success as the gold standard of treatment:

Depression
PTSD
Postpartum Depression
Suicidal Ideation
Obsessive Compulsive Disorder
Bipolar Disorder
Anxiety and Social Anxiety Disorder
Migraines

Recent Research and Blog Posts:

New Hope for Treatment-Resistant Depression With Ketamine

Right as Rain by UW Medicine

“There is no one treatment for depression, and what could work for one person might not work for another. On one hand, it can feel reassuring to know that there are so many treatment options available. But on the other hand, for people with treatment-resistant depression, it can feel like a never-ending cycle of trial-and-error. I’ve experienced this first-hand. For over a decade, I’ve worked with psychiatrists to create treatment plans that range from an array of antidepressants to exercise to extra vitamin D, only to feel the same — or worse — every time. After learning about ketamine-assisted therapy, I decided to give it a try — and quickly understood why it’s a growing option for those looking for relief. ” Read More

Ketamine found effective in treating severe depression

The Harvard Gazette, May 2023

Had no major side effects compared to electroconvulsive therapy, considered the ‘gold standard’ treatment

“People with treatment-resistant depression suffer a great deal, so it is exciting that studies like this are adding new options for them,” said Anand. “With this real-world trial, the results are immediately transferable to the clinical setting.” Read More

Pitt researchers lead groundbreaking study on ketamine treatments for depression

“Ketamine is an anesthetic that has been used for years. It was only by chance that it was found to help people suffering from depression….By creating a burst of plasticity of the brain,” Price said. “The brain tends to be impacted by chronic stress and when you are in a state of depression you find the brain has lost some of it’s its flexibility and plasticity. Ketamine seems to quickly restore that in the brain,” she added.” Read More

Could a drug prevent depression and PTSD?

“The path to better medicine is paved with accidental yet revolutionary discoveries. In this well-told tale of how science happens, neuroscientist Rebecca Brachman shares news of a serendipitous breakthrough treatment that may prevent mental disorders like depression and PTSD from ever developing. And listen for an unexpected — and controversial — twist.” Watch the Video Here

Dissociative Intravenous Ketamine Infusion for Depression

“Garrett Halweg, M.D. discusses the use of Ketamine to rapidly reverse severe depression and thoughts of suicide. This technique is empowering family and friends to know what to do when someone tells you, “I want to kill myself” or “I don’t want live anymore!” Watch the Video Here

Restoring Mood Balance in Depression

“One of the most novel and exciting findings in major depressive disorder research over the last decade is the discovery of the fast-acting and long-lasting antidepressant effects of ketamine. Indeed, the therapeutic effects of classic antidepressant such as SSRIs require a month or longer to be expressed, with about a third of MDD patients resistant to treatment. Clinical studies have shown that low dose of ketamine exhibits fast-acting relatively sustained antidepressant action even in treatment-resistant patients…” Read More from this Article

Ketamine for Social Anxiety Disorder

“Many patients with social anxiety disorder (SAD) experience inadequate symptom relief from available treatments. Ketamine is a potent N-methyl-D-aspartate (NMDA) receptor antagonist with a potentially novel mechanism of action for the treatment of anxiety disorders. Therefore, we conducted a double-blind, randomized, placebo-controlled crossover trial in 18 adults with DSM-5 SAD and compared the effects between intravenous ketamine (0.5 mg/kg over 40 min) and placebo (normal saline) on social phobia symptoms…” Read Full Article Here